Kalaris Therapeutics shares owned by Propel Bio Management
Quarter-by-quarter ownership of Kalaris Therapeutics (KLRS) shares owned by Propel Bio Management
from 13F filings
Historical chart of Propel Bio Management investment in Kalaris Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kalaris Therapeutics held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Kalaris Therapeutics by Propel Bio Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $355k | 42k | 8.44 |